H eart tissue engineering evolved with the aim of replacing damaged myocardium with a cardiac patch with structural and functional properties resembling the native tissue (1) (2) (3) . The myocardium has a complex 3D architecture composed of a cellular component and an intricate fibrous network of the structural extracellular matrix (ECM) (4) . Each layer of these fibers guides cell organization to form anisotropic sheets of myocardial syncytia that are responsible for directional contractions (5, 6) . A slight shift in the alignment of adjacent layers ensures a circular contraction and leads to a strong pump function (6) . To support the high metabolic demand of the contracting tissue, a dense vascular network between several cell layers provides oxygen and nutrients to the surrounding cells. Because heart muscle function is highly dependent on this unique structural organization, recapitulating both its anisotropic geometry throughout the ventricle wall and the internal vasculature is pivotal for engineering functional cardiac tissues that can be used in regenerative applications (7) .
Numerous approaches have been used to recapitulate different structural properties of the heart (7) (8) (9) (10) (11) . Technologies such as lithography and microfabrication enabled precise control over the biomaterial pattern and thus over the induced cell alignment and anisotropic electrical signal transfer (8, 12) . However, using these techniques for engineering thick 3D tissues with multicellular layers is still a challenge. On the other hand, macroporous scaffolds and hydrogels are suitable for engineering thick 3D tissues, but with these scaffolds the different tissue layers cannot be controlled separately (13) (14) (15) (16) . Thus, the cells throughout the entire scaffold are exposed to the same culture conditions, topography, and biochemical content, and different tissue compartments cannot be engineered separately. For example, because cardiac cells and blood vessel cells require different culture medium and distinct ECM structure and composition, and mature at different time points, engineering spatially controlled vasculature within a cardiac patch may be a challenge (17, 18) . To overcome these challenges, recent advances in lithographic methods have enabled the layer-bylayer assembly of anisotropic 3D cardiac tissues and a vascular compartment embedded within them (19) (20) (21) . For example, Zhang and colleagues (21) have reported on the production of a biodegradable scaffold with a built-in vasculature. In a different study Ye and colleagues (20) reported the stacking of elastomeric microvessels and heart cell scaffolds to form 3D vascularized tissues. However, the scaffolds used to create the layers do not recapitulate the fibrous nature of the cardiac ECM, which is essential for tissue maturation.
Electrospinning is a well-established method used in tissue engineering to fabricate fibrous scaffolds (9, 10, (22) (23) (24) . We have recently reported on the potential of albumin fiber scaffolds to promote the assembly of anisotropic and functional cardiac patches. However, their relatively low thickness (∼100 μm) may limit their clinical applicability (24) . Here, we propose to overcome these challenges by a bottom-up design approach in which each layer of the engineered tissue has a distinct role. Electrospun fibrous layers were laser-patterned to create distinct, predefined architectures to support cardiac cells or blood vessel-forming cells. The patterned scaffolds had three distinct architectures: (i) microgrooves to promote the assembly of aligned cardiac tissues, (ii) microtunnels with side cages to accommodate endothelial cells and microparticles that slowly release VEGF, respectively, and (iii) microcage-like structures for the entrapment of poly(lactic-co-glycolic acid) (PLGA) microparticles that control the release of anti-inflammatory drugs into the exterior microenvironment (Fig. 1) . Each individual layer Significance Heart disease is the primary cause of death in the United States. Cardiac tissue engineering has evolved with the goal of creating heart patches to treat end-stage patients. Here, we report on a bottom-up approach to assemble a modular cardiac patch that consists of various tissue layers, each performing a different function. One layer was designed to accommodate cardiac cells and promote their organization into a contracting tissue. Another layer enables the organization of endothelial cells into blood vessels, and layers with microparticulate systems enable the controlled release of different biofactors affecting the engineered tissue or the host. We have shown that the patch can be assembled from its building blocks just before transplantation and can perform in the body. was characterized separately for structure and function, and the entire patch was assembled just before transplantation. Finally, the structure of the assembled multilayer cardiac patch was characterized before transplantation, and its ability to promote vascularization was assessed in vivo.
Results and Discussion
Tissues in the body are comprised of different cellular and extracellular layers. The myocardium is composed of anisotropic layers of cells and collagen fibers with varying orientations across its transmural depth (5, 6) . To explore the variations in transmural orientation in detail, adult rat hearts were harvested, sliced, and stained for cells and collagens ( Fig. 2A) . Analysis of collagen fiber orientation revealed that the degree of alignment from the epicardial side to the endocardial side had a 100°shift (SI Materials and Methods and Fig. S1 ). Currently, the only technique for assembling a shift in cell alignment is by assembling several tissue layers atop each other. To address this challenge, thin layers of fibrous scaffolds were fabricated by electrospinning of albumin (Fig. 2B) . To increase the surface area of the fibrous scaffold and to mimic native anisotropy of the natural ECM, microgrooves were patterned onto the scaffold by a femtosecond laser (Fig. 2C , SI Materials and Methods, and Fig. S2A ). To increase the mass transfer through the different layers, microholes (40 ± 0.8 μm in diameter) were created on the ridges of each layer (Fig. 2C ). Such holes were previously shown to promote the efficient exchange of nutrients and oxygen (21) . The pattern dimensions as measured using scanning laser confocal microscopy were a groove width of 115 ± 5 μm, ridge width of 120 ± 2 μm, and height of 110 ± 10 μm (Fig. 2D , SI Materials and Methods, and Fig. S2B ). The patterned grooves increased the surface area of the scaffolds significantly, from 25 mm 2 to 39 ± 0.9 mm 2 (P = 0.0001) (Fig. 2E ). Stacking several of these grooved scaffolds with a slight angle shift (Fig. 2F ) may promote the essential circular contraction.
For proper integration with the healthy part of the heart, the mechanical properties of the patch should have similar characteristics. The Young's modulus of the human heart ranges between 200 and 500 kPa in the contracted state (25) (26) (27) . Moreover, the left ventricle (LV) has unique mechanical anisotropy, with a measured anisotropy ratio of 2.1, that is essential for proper function (7) . Fig. 2G shows the representative stress-strain behavior of the different scaffolds. Further analysis of these results revealed that, although the Young's modulus of the planar layers was 950 ± 125 kPa, the microgrooved scaffolds had significantly lower Young's modulus of 450 ± 20 kPa in the long axis of the grooves and 95 ± 25 kPa in the short axis (P = 0.0002 and P = 0.004, respectively) (Fig. 2H) . The anisotropy ratio of the grooved scaffolds was 2.3, indicating their resemblance to the anisotropic LV and their potential use in cardiac patches that generate a strong contraction force. The mechanical properties and anisotropy can be controlled further by patterning different structures (SI Materials and Methods and Fig. S3) .
Next, we sought to evaluate the potential of the grooved fibrous layers to promote anisotropic cardiac tissue assembly. Cardiac cells were isolated from the ventricles of neonatal rats and were cultured for 7 d. Sarcomeric α-actinin immunostaining revealed that the cells cultured on the nonpatterned albumin fiber scaffolds assembled into a randomly oriented tissue (Fig. 3A) . On the contrary, the cells in the grooved scaffolds acquired the micropattern and assembled into aligned cardiac cell bundles, as they would in their natural microenvironment (Fig. 3B ). Higher-magnification images of the tissues revealed cell elongation and massive striation in both scaffolds. However, only the cells on the grooved scaffolds exhibited oriented striation (Fig. 3B) . Side-view images revealed that, contrary to the planar scaffolds, cardiomyocytes in the patterned scaffolds were able to adhere to the walls of the grooves and thus formed thicker 3D structures ( Fig. 3 A and B) , with high expression of connexin 43 proteins, which are associated with electrical coupling between adjacent cells (Fig. 3C) . Because tissue structure usually is translated to function, an analysis of the electrical signal propagation was performed by calcium imaging (Movies S1 and S2). As shown by the heat maps, while the electrical signal generated by the tissues cultured within the planar scaffolds propagated randomly (Fig. 3D) , the cells in the patterned scaffolds transferred the signal in the direction of the grooves (Fig.  3E and Fig. S4 ). Analysis of electrical signal propagation at randomly chosen points revealed directional propagation only in the A major challenge that jeopardizes the clinical translation of engineered tissues is the inability to form and maintain thick, viable tissues (28, 29) . 3D-engineered tissues require an efficient and constant supply of oxygen and nutrients for cell growth and function. In vitro, in the absence of a functional vascular network, perfusion bioreactors are used for mass transfer to the core of the tissue (30, 31) . However, once the tissues are transplanted, the lack of proper vasculature jeopardizes the success of the treatment (32) . One of the strategies for engineering prevascularized cardiac tissues is the coculture of cardiac cells with blood vessel-forming cells such as endothelial cells (33, 34) . However, the two cell types require distinct conditions, including culture medium, growth factors, ECM topography and composition, and cultivation time. Here we designed a platform that allows separate growth, maturation, and organization of the endothelial cells that then are integrated with the cardiac compartment. Microtunnels with dimensions of 450 μm were patterned to form a predefined vasculature (Fig. 4 A and B) . Cage-like structures were designed between the tunnels to accommodate controlled-release systems to continuously supply signals for vascularization. Next, double-emulsion PLGA microparticles (Fig. 4C ) enabling a long-term release of VEGF (Fig. 4D) were deposited into the cages (Fig. 4E) . Such a VEGF-release profile has been shown to improve the vascularization of an engineered tissue and to encourage anastomosis in vivo, contributing to better engraftment after transplantation (35, 36) . The microtunnels then were seeded with endothelial cells to form large, closed lumens (Fig. 4F) . VEGF release from the engineered blood vessels may encourage further sprouting of endothelial cells and the formation of new capillaries between the precultured vessels (36) . Furthermore, the particles can be inserted into the cages more accurately by using a microinjector and even can be loaded with other growth factors or cytokines, such as PDGF or SDF-1, to attract other blood vessel-forming cells or IGF-1 for cardioprotection (37) .
Another challenge in tissue engineering is the host response to the transplanted tissue. An acute inflammatory response against the engineered patch could profoundly limit the success of its integration and thereby jeopardize the regeneration process (38) . Therefore, we next sought to incorporate a second microparticulate layer to release an anti-inflammatory drug from the patch's outskirts to its surroundings. Cage-like structures were patterned (Fig.  4 G and H) , and PLGA microparticles containing dexamethasone (DEX) were scattered on top (Fig. 4I) . This anti-inflammatory layer was able to release the drug for at least 14 d (Fig. 4J) and attenuated the activation of macrophages, as measured by their nitric oxide (NO) secretion (Fig. 4K ). Although this layer was designed to affect the patch's surroundings by decreasing the immune response after transplantation, other small molecules can be loaded into the particles to affect the engineered tissue as well. For example, noradrenaline release near the cardiac layers may increase the contraction rate of the tissue. Recently our group has shown the ability to trigger the release of drugs by built-in layers of electronics (39) . Integration of such a system as an additional layer within the engineered patch could provide on-demand spatiotemporal release of the different biofactors.
After engineering the distinct tissue layers, we next sought to integrate them to form a thick, modular tissue. Recently, our laboratory developed a thermoresponsive ECM-based hydrogel as a platform for cell delivery and tissue engineering (15) . Here, we used the ability of the hydrogel to solidify at 37°C to serve as a biological glue for layer integration. Thin layers of the glue were deposited between the tissue layers, and the assembled patch was heated to 37°C in an incubator. Integration then was assessed by SEM, histology, and immunostaining ( Fig. 5 B and C, SI Materials and Methods, and Fig. S6 B and C) . Although the ECM hydrogel was able to glue the layers, the layers were not tightly packed, allowing the diffusion of nutrients and oxygen. Next, the binding force between the different layers was assessed (Fig. 5D) . As shown by the measurements of tensile strength immediately after integration, the force needed to separate the glued layers was significantly greater than the force needed to separate nonglued layers (P = 0.03). More importantly, the binding force between the ECMglued layers was strong enough to withstand manual manipulation and surgical suturing to the host. Culturing the integrated layers further for 7 d significantly strengthened their adherence (P = 0.0002), possibly via the additional secretion of ECM proteins by the cells.
Because cardiac tissues and blood vessels may need different assembly conditions (including cultivation periods, growth factors, and supporting matrices), 7-d cardiac layers and 3-d endothelial cell layers were integrated together with the controlled-release layers to form a 5-mm-thick cardiac patch. The engineered tissue was composed of six cardiac layers, six endothelial cell layers with VEGF particles, and two layers of DEX-releasing microparticles (Fig. 5E) . To create the closed lumens, two layers of vasculature were simply glued on top of each other and were incorporated between two cardiac tissue layers (SI Materials and Methods and Fig. S6D ). The DEX layers were integrated to both ends of the construct to affect the patch's surroundings (SI Materials and Methods and Fig. S6E ).
Because the native myocardium has tight connections in all directions, we next sought to evaluate the electrical coupling in the z-direction between the different cardiac layers. Before cardiac cell seeding, thin metal electrodes were deposited on an electrospun fiber scaffold, enabling local electrical stimulation of the cells within. Next, five layers of cardiac tissues were stacked on this electrodecontaining layer to create the thick patch with an upper cardiac layer that was pretreated with calcium dye. Then electrical stimuli (1 or 2 Hz) were applied to the bottom layer, and the corresponding calcium wave fronts were recorded from the upper layer, indicating electrical integration within the z-direction (Fig. 5F and Movie S3).
Finally, we assessed the ability of our modular cardiac patch to promote vascularization in vivo. Cellular patches with or without VEGF-releasing microparticles were s.c. transplanted in rats for 2 wk before the rats were killed. A macroscopic view of the patches in the animals suggested that, while the patches without the VEGF remained white, the VEGF-loaded patches were filled with blood vessels as indicated by their red color (Fig. 5 G  and H) . Cross-sectioning the patches revealed that the structure of the layers was maintained (Fig. 5 I and J) . Furthermore, VEGF microparticles could be seen on the blood-vessel layer, suggesting that although the particles had started to degrade and release their content, some of them were still intact within their mesh (SI Materials and Methods and Fig. S6F ). Histological analysis and immunostaining the extracts for smooth muscle cells, which stabilize blood vessels, revealed that the release of VEGF encouraged the infiltration of blood vessels into the patch and its surroundings (Fig. 5 K and L, SI Materials and Methods, and Fig. S7) . Moreover, red blood cells within the host blood vessels were seen entering the core of the patch and into its channels, indicating anastomosis between the host vasculature and the engineered tissue (Fig. 5K) . Quantification of blood vessels within the engineered patch revealed a significantly higher number of vessels per square millimeter of tissue (P = 0.007) (Fig. 5M) in the patch containing VEGF-releasing particles than in the pristine scaffolds. Moreover, the percentage of the total area of blood vessels within the VEGF-releasing patch was significantly higher (P = 0.0004) (Fig. 5N) . Taken together, these results indicate the ability of the VEGF microparticulate layer to improve blood vessel infiltration into the cardiac patch.
To conclude, here we present a platform for assembling a modular, thick, cardiac patch, containing layers of cardiac tissues, blood vessels, and proangiogenic and anti-inflammatory factors. The 3D structural complexity of the fibrous ECM was recapitulated by the assembly of micropatterned electrospun layers, mimicking the variation in collagen alignment throughout the LV wall. We have shown that these layers mimic both the stiffness and mechanical anisotropy of the heart muscle and therefore may improve the potential of the cardiac patch to integrate properly to the heart muscle. Cardiac cells cultured within these layers assembled into aligned and elongated cardiac bundles resembling the natural tissue morphology. In addition, we have engineered predefined vasculature with sufficient distance from the cardiac tissue to enable the diffusion of oxygen and nutrients. This platform enabled a simple, scalable production of millimeter-thick tissues simply by placing one on top of another and integrating them by an ECM-based biological glue. Unlike other tissue-engineering approaches, such as 3D printing or using macroporous scaffolds, this method enabled the engineering of individual layers with each layer cultured under its optimal conditions before assembly. Microparticulate systems for prolonged release of growth factors or small molecules could be incorporated into the patch easily and affected the engineered tissue or the host according to the physiological needs. Although our data support the engineering of a vascularized cardiac patch, in the future different structures can be patterned on electrospun fibers to provide support to other tissues that are comprised of defined layers, including the liver and lung.
Materials and Methods
Detailed descriptions of scaffold fabrication, mechanical testing, cardiac cell isolation and seeding, immunostaining, calcium imaging, electrical signal transfer analysis, PLGA microparticle fabrication, macrophage activation test, ELISA analysis, in vivo implantation, histology, and imaging, are provided in SI Materials and Methods. All animal experiments were performed according to Tel Aviv University ethical use protocols.
